FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PTPRK-THEMIS

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PTPRK-THEMIS
FusionPDB ID: 70468
FusionGDB2.0 ID: 70468
HgeneTgene
Gene symbol

PTPRK

THEMIS

Gene ID

5796

387357

Gene nameprotein tyrosine phosphatase receptor type Kthymocyte selection associated
SynonymsR-PTP-kappaC6orf190|C6orf207|GASP|SPOT|TSEPA
Cytomap

6q22.33

6q22.33

Type of geneprotein-codingprotein-coding
Descriptionreceptor-type tyrosine-protein phosphatase kappadJ480J14.2.1 (protein tyrosine phosphatase, receptor type, K (R-PTP-KAPPA, protein tyrosine phosphatase kappa , protein tyrosine phosphatase kappaprotein-tyrosine phosphatase kappaprotein-tyrosine phosphaprotein THEMISGRB2-associated proteinsignaling phosphoprotein specific for T cellsthymocyte selection pathway associatedthymocyte-expressed molecule involved in selection
Modification date2020032220200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000368207, ENST00000368210, 
ENST00000368213, ENST00000368215, 
ENST00000368226, ENST00000368227, 
ENST00000532331, ENST00000524481, 
ENST00000525459, 
ENST00000368248, 
ENST00000368250, ENST00000537166, 
ENST00000543064, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score36 X 18 X 16=103686 X 7 X 5=210
# samples 4810
** MAII scorelog2(48/10368*10)=-4.43295940727611
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(10/210*10)=-1.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PTPRK [Title/Abstract] AND THEMIS [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PTPRK [Title/Abstract] AND THEMIS [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PTPRK(128385903)-THEMIS(128176333), # samples:1
PTPRK(128841404)-THEMIS(128040968), # samples:1
PTPRK(128505577)-THEMIS(128031161), # samples:1
PTPRK(128385903)-THEMIS(128040968), # samples:1
PTPRK(128505576)-THEMIS(128031160), # samples:1
Anticipated loss of major functional domain due to fusion event.PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
PTPRK-THEMIS seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePTPRK

GO:0006470

protein dephosphorylation

16263724

HgenePTPRK

GO:0007165

signal transduction

16849327

HgenePTPRK

GO:0007179

transforming growth factor beta receptor signaling pathway

15899872

HgenePTPRK

GO:0008285

negative regulation of cell proliferation

15899872|18276111

HgenePTPRK

GO:0010839

negative regulation of keratinocyte proliferation

16263724

HgenePTPRK

GO:0030336

negative regulation of cell migration

18276111

HgenePTPRK

GO:0034394

protein localization to cell surface

18276111

HgenePTPRK

GO:0034614

cellular response to reactive oxygen species

16849327

HgenePTPRK

GO:0034644

cellular response to UV

16849327

HgenePTPRK

GO:0045786

negative regulation of cell cycle

15899872

HgenePTPRK

GO:0045892

negative regulation of transcription, DNA-templated

18276111



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:128385903/chr6:128176333)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PTPRK (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across THEMIS (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000368226PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-24974165570186
ENST00000368226PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-23754164572152
ENST00000368226PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-23754164572152
ENST00000368226PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-23754164572152
ENST00000368227PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-25484676080203
ENST00000368227PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-24264675082169
ENST00000368227PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-24264675082169
ENST00000368227PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-24264675082169
ENST00000532331PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-22992182385127
ENST00000532331PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-21772182385127
ENST00000532331PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-21772182385127
ENST00000532331PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-21772182385127
ENST00000368213PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-24063254662155
ENST00000368213PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-2284325109492127
ENST00000368213PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-2284325109492127
ENST00000368213PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-2284325109492127
ENST00000368210PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-24393584992166
ENST00000368210PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-23173583991133
ENST00000368210PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-23173583991133
ENST00000368210PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-23173583991133
ENST00000368215PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-21811001026785
ENST00000368215PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-20591001026785
ENST00000368215PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-20591001026785
ENST00000368215PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-20591001026785
ENST00000368207PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-24063254662155
ENST00000368207PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-2284325109492127
ENST00000368207PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-2284325109492127
ENST00000368207PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-2284325109492127
ENST00000525459PTPRKchr6128841404-ENST00000368250THEMISchr6128040968-24103294700157
ENST00000525459PTPRKchr6128841404-ENST00000368248THEMISchr6128040968-2288329113496127
ENST00000525459PTPRKchr6128841404-ENST00000543064THEMISchr6128040968-2288329113496127
ENST00000525459PTPRKchr6128841404-ENST00000537166THEMISchr6128040968-2288329113496127
ENST00000368226PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-342314781091509466
ENST00000368227PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-347415291601560466
ENST00000532331PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-32251280911311406
ENST00000368213PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-33321387181418466
ENST00000368210PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-33651420511451466
ENST00000368215PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-3107116201193397
ENST00000368207PTPRKchr6128505577-ENST00000368250THEMISchr6128031161-33321387181418466
ENST00000368226PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-342314781091509466
ENST00000368227PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-347415291601560466
ENST00000532331PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-32251280911311406
ENST00000368213PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-33321387181418466
ENST00000368210PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-33651420511451466
ENST00000368215PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-3107116201193397
ENST00000368207PTPRKchr6128505576-ENST00000368250THEMISchr6128031160-33321387181418466

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000368226ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.676114860.32388514
ENST00000368226ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.61756510.38243493
ENST00000368226ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.61756510.38243493
ENST00000368226ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.61756510.38243493
ENST00000368227ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.89031190.10968808
ENST00000368227ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.8927660.10723404
ENST00000368227ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.8927660.10723404
ENST00000368227ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.8927660.10723404
ENST00000532331ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.912092450.08790753
ENST00000532331ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.846101760.15389821
ENST00000532331ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.846101760.15389821
ENST00000532331ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.846101760.15389821
ENST00000368213ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.831243930.16875602
ENST00000368213ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000368213ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000368213ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000368210ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.7907460.20925398
ENST00000368210ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.807176950.19282305
ENST00000368210ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.807176950.19282305
ENST00000368210ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.807176950.19282305
ENST00000368215ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.72334890.27665105
ENST00000368215ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.72941460.27058542
ENST00000368215ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.72941460.27058542
ENST00000368215ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.72941460.27058542
ENST00000368207ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.831243930.16875602
ENST00000368207ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000368207ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000368207ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.837787870.16221215
ENST00000525459ENST00000368250PTPRKchr6128841404-THEMISchr6128040968-0.570425750.42957428
ENST00000525459ENST00000368248PTPRKchr6128841404-THEMISchr6128040968-0.59800680.4019932
ENST00000525459ENST00000543064PTPRKchr6128841404-THEMISchr6128040968-0.59800680.4019932
ENST00000525459ENST00000537166PTPRKchr6128841404-THEMISchr6128040968-0.59800680.4019932
ENST00000368226ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001466630.9998534
ENST00000368227ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001481180.9998518
ENST00000532331ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.000133240.9998667
ENST00000368213ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001382940.9998617
ENST00000368210ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001444740.9998555
ENST00000368215ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001288930.99987113
ENST00000368207ENST00000368250PTPRKchr6128505577-THEMISchr6128031161-0.0001382940.9998617
ENST00000368226ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001466630.9998534
ENST00000368227ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001481180.9998518
ENST00000532331ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.000133240.9998667
ENST00000368213ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001382940.9998617
ENST00000368210ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001444740.9998555
ENST00000368215ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001288930.99987113
ENST00000368207ENST00000368250PTPRKchr6128505576-THEMISchr6128031160-0.0001382940.9998617

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PTPRK-THEMIS

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PTPRKchr6128841404THEMISchr612804096810027SLLGLSWDRPKASSPQRHHVDITKKL
PTPRKchr6128841404THEMISchr612804096821869SLLGLSWDRPKASSPQRHHVDITKKL
PTPRKchr6128841404THEMISchr612804096832569SLLGLSWDRPKASSPQRHHVDITKKL
PTPRKchr6128841404THEMISchr612804096832969SLLGLSWDRPKASSPQRHHVDITKKL

Top

Potential FusionNeoAntigen Information of PTPRK-THEMIS in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTPRK-THEMIS_128841404_128040968.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTPRK-THEMISchr6128841404chr6128040968325HLA-A30:08ASSPQRHHV0.92570.77631120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C01:30SSPQRHHV0.97660.9231220
PTPRK-THEMISchr6128841404chr6128040968325HLA-C01:17SSPQRHHV0.96460.89261220
PTPRK-THEMISchr6128841404chr6128040968325HLA-C15:04ASSPQRHHV0.99960.81981120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C15:06ASSPQRHHV0.99960.84711120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C06:03ASSPQRHHV0.98840.98191120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C12:04ASSPQRHHV0.98440.98891120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C12:12ASSPQRHHV0.96680.84291120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C02:06ASSPQRHHV0.94810.93841120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C01:03SSPQRHHV0.99280.76361220
PTPRK-THEMISchr6128841404chr6128040968325HLA-C01:02SSPQRHHV0.9770.88831220
PTPRK-THEMISchr6128841404chr6128040968325HLA-C15:05ASSPQRHHV0.99970.87181120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C15:02ASSPQRHHV0.99970.77761120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C15:09ASSPQRHHV0.99960.81981120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C16:02ASSPQRHHV0.99170.99221120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C06:17ASSPQRHHV0.99120.98721120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C06:02ASSPQRHHV0.99120.98721120
PTPRK-THEMISchr6128841404chr6128040968325HLA-B07:09RPKASSPQR0.98880.6012817
PTPRK-THEMISchr6128841404chr6128040968325HLA-C16:04ASSPQRHHV0.98480.94911120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C12:03ASSPQRHHV0.97450.94421120
PTPRK-THEMISchr6128841404chr6128040968325HLA-A30:01ASSPQRHHV0.91760.84571120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C16:01ASSPQRHHV0.91310.9691120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C07:04ASSPQRHHV0.90810.9151120
PTPRK-THEMISchr6128841404chr6128040968325HLA-C06:08ASSPQRHHV0.85220.98731120
PTPRK-THEMISchr6128841404chr6128040968325HLA-B07:13ASSPQRHHV0.35750.79891120

Top

Potential FusionNeoAntigen Information of PTPRK-THEMIS in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of PTPRK-THEMIS

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10437WDRPKASSPQRHHVPTPRKTHEMISchr6128841404chr6128040968325

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PTPRK-THEMIS

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10437WDRPKASSPQRHHV-7.19905-7.31085
HLA-B14:023BVN10437WDRPKASSPQRHHV-4.95643-5.99953
HLA-B52:013W3910437WDRPKASSPQRHHV-5.83545-5.94725
HLA-B52:013W3910437WDRPKASSPQRHHV-5.05006-6.09316
HLA-A24:025HGA10437WDRPKASSPQRHHV-7.70134-7.81314
HLA-A24:025HGA10437WDRPKASSPQRHHV-3.44118-4.48428
HLA-B27:056PYJ10437WDRPKASSPQRHHV-9.10792-9.21972
HLA-B44:053DX810437WDRPKASSPQRHHV-4.82059-4.93239
HLA-B44:053DX810437WDRPKASSPQRHHV-3.88198-4.92508
HLA-B35:011A1N10437WDRPKASSPQRHHV-6.3585-6.4703
HLA-B35:011A1N10437WDRPKASSPQRHHV-4.11277-5.15587
HLA-A02:016TDR10437WDRPKASSPQRHHV-2.45382-2.56562

Top

Vaccine Design for the FusionNeoAntigens of PTPRK-THEMIS

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PTPRK-THEMISchr6128841404chr61280409681120ASSPQRHHVCCGCAGCGTCATCACGTAGACATAACC
PTPRK-THEMISchr6128841404chr61280409681220SSPQRHHVCAGCGTCATCACGTAGACATAACC
PTPRK-THEMISchr6128841404chr6128040968817RPKASSPQRGCCAGTTCTCCGCAGCGTCATCACGTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of PTPRK-THEMIS

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAPTPRK-THEMISchr6128841404ENST00000368207chr6128040968ENST00000368248TCGA-E2-A105-01A

Top

Potential target of CAR-T therapy development for PTPRK-THEMIS

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PTPRK-THEMIS

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PTPRK-THEMIS

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource